Risteys · H7_IRIDOLENS

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H20.2 Cause of death: ICD-10 — H20.2 2 out of 7 registries used, show all original rules.	60
4. Check minimum number of events None	60
5. Include endpoints None	60
6. Filter based on genotype QC (FinnGen only)	60

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	330	171	157
Only index persons	311	165	146
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	53.04	53.69	52.23
Only index persons	53.04	53.29	52.76

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	60	33	27
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	57.46	54.93	60.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
55: Matched controls
551

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H20.2

ICD-10 Finland

Lens-induced iridocyclitis

+∞

78.8

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

+∞

39.4

H20.1

ICD-10 Finland

Chronic iridocyclitis

+∞

16.5

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

61.2

12.6

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

10.8

11.2

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

75.1

11.1

S01ED01

ATC

timolol; ophthalmic

23.7

9.5

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

19.2

7.6

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

8.9

7.5

S01ED51

ATC

timolol, combinations; ophthalmic

8.9

7.1

S01FA04

ATC

cyclopentolate; ophthalmic

45.8

7.0

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

78.6

6.6

H26.2

ICD-10 Finland

Complicated cataract

78.6

6.6

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

+∞

6.4

S01EA03

ATC

apraclonidine; ophthalmic

+∞

6.4

WX140

NOMESCO Finland

Parabulbar anesthesy

9.2

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

186

2.91

3.98

4.5

3.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

286

3.02

3.59

11.8

9.9

4.3

4.4

e9/l

0.03

252

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3.70

3.43

3.7

1.8

717.7

191.7

ng/l

0.40

(42870588) Differential panel, method unspecified - Blood

163

2.68

3.43

12.2

4.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

102

2.83

3.41

6.8

6.5

—

(3018418) pH of Serum or Plasma

157

2.64

3.31

5.1

4.0

7.4

—

(3001604) Monocytes [#/volume] in Blood

237

2.65

3.22

12.1

5.5

0.6

e9/l

0.19

208

(3006315) Basophils [#/volume] in Blood

238

2.63

3.18

12.0

5.4

0.0

e9/l

1.22

209

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

396

3.34

3.13

9.8

7.7

89.7

77.8

u/l

0.68

370

(3013115) Eosinophils [#/volume] in Blood

249

2.62

3.11

12.0

5.6

0.2

e9/l

0.13

223

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

248

2.45

2.78

6.1

7.0

1.2

mmol/l

0.10

211

(3022096) Basophils/100 leukocytes in Blood

222

2.38

2.70

13.0

5.2

0.7

0.6

0.17

208

(3020891) Body temperature

4.23

2.56

3.0

4.5

—

(3006504) Eosinophils/100 leukocytes in Blood

226

2.32

2.54

13.1

5.4

2.9

2.8

0.18

214

(3018010) Neutrophils/100 leukocytes in Blood

226

2.32

2.54

12.4

5.7

56.9

58.5

0.44

213

(36304419) Bacteria [Presence] in Urine

141

2.33

2.48

3.4

2.9

—

(3019069) Monocytes/100 leukocytes in Blood

228

2.28

2.47

13.6

5.9

8.4

0.03

217

(4034850)

6.69

2.42

9.6

7.5

—

(3030467) Casts [#/volume] in Urine by Automated count

144

2.26

2.34

3.6

3.0

0.3

0.4

e6/l

0.13

111

(3002030) Lymphocytes/100 leukocytes in Blood

233

2.21

2.28

13.5

5.8

28.1

27.0

0.31

219

(3009445) Proteinase 3 Ab [Units/volume] in Serum

4.03

2.22

1.0

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

247

2.14

2.12

6.4

5.2

0.0

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

247

2.14

2.12

5.1

3.8

0.0

estimate

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

5.34

2.11

1.0

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

245

2.03

1.88

5.1

3.8

0.0

estimate

—

(3052851) Hemolysis interference index of Serum or Plasma

4.44

1.86

12.2

3.5

—

(3032080) INR in Blood by Coagulation assay

212

1.96

1.74

13.1

6.0

1.2

1.3

inr

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2.13

1.69

1.4

1.6

1301.8

1218.8

nmol/l

0.12

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.47

1.69

1.5

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

112

2.02

1.60

1.6

2.6

—

(3029937) Albumin [Presence] in Urine by Test strip

138

1.94

1.55

6.2

4.1

0.0

estimate

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

200

1.87

1.54

3.2

3.5

20.5

40.3

ng/l

0.68

141

(46235355) HIV 1 and 2 tests - Meaningful Use set

2.20

1.52

1.5

1.7

—

(3018095) Leukocytes [#/volume] in Urine

192

1.86

1.51

4.1

3.6

827.1

69.3

e6/l

0.45

137

(3037467) Urinalysis macro (dipstick) panel - Urine

340

1.93

1.46

6.4

4.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

194

1.83

1.44

5.7

4.1

—

(3019060) Gas panel - Arterial blood

2.40

1.44

2.7

4.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

235

1.78

1.34

3.1

4.3

—

(40761536) Microorganisms panel - Urine sediment

2.23

1.34

5.6

3.6

—

(40758558) Short blood count panel - Blood

130

1.81

1.24

7.8

7.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2.21

1.20

2.9

3.6

1.2

mmol/l

—

(3020682) Albumin/Creatinine [Ratio] in Urine

149

1.75

1.18

5.1

4.1

3.1

7.4

mg/mmol

0.98

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2.11

1.14

3.2

2.5

17.5

8.8

umol/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2.02

1.11

1.6

1.5

—

(40761535) Cells panel - Urine sediment

2.17

1.11

6.7

3.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.87

1.09

1.3

3.1

0.8

mmol/l

0.09

(36660697) Celiac disease serology panel - Serum

2.20

1.07

1.1

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

163

1.67

1.03

1.9

2.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2.01

0.97

3.1

9.8

1.5

1.6

—

(3026008) Bacteria identified in Urine by Culture

158

1.62

0.93

3.5

3.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.18

0.92

9.0

6.5

26.4

26.0

mmol/l

—

(3012516) Albumin [Mass/volume] in Urine

142

1.61

0.88

4.1

3.3

26.8

49.2

mg/l

0.76

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.97

0.84

1.5

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

118

1.61

0.81

5.9

3.5

—

(3023520) Reticulocytes [#/volume] in Blood

1.82

0.80

5.8

3.5

74.7

70.1

e9/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.82

0.80

4.7

10.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

136

1.58

0.80

4.3

3.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1.72

0.79

1.1

1.3

1.0

10.3

u/ml

—

(3031040) Bacteria [#/volume] in Urine by Automated count

330

1.52

0.75

6.5

4.2

—

40.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.85

0.74

1.0

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.77

0.74

1.2

1.4

—

(3000991) Gas panel - Venous blood

1.71

0.69

3.6

9.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1.65

0.69

2.8

2.6

1.0

0.8

e6/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.70

0.66

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

421

1.54

0.62

27.4

17.9

13.8

13.9

0.11

412

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

0.00

0.61

0.0

4.1

—

24.7

—

(3037121) Protein [Mass/volume] in Urine

0.00

0.61

0.0

4.1

—

0.2

—

(4010399)

1.85

0.61

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.85

0.61

2.3

1.6

—

(1002224) Polysomnography panel

0.00

0.59

0.0

1.0

—

(3023368) Bacteria identified in Blood by Culture

146

1.44

0.56

3.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

292

1.38

0.53

2.8

2.9

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.55

0.50

5.3

1.9

408.1

403.0

nmol/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

141

1.40

0.48

7.1

4.7

18.4

22.6

0.62

(3042936) Bacteria identified in Isolate by Culture

1.50

0.47

1.5

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

101

0.65

0.44

1.4

1.3

—

0.9

—

(3017732) Neutrophils [#/volume] in Blood

1.61

0.43

1.4

2.7

5.1

3.2

e9/l

—

(3044889) 12 lead EKG panel

359

1.34

0.43

5.2

3.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

0.00

0.41

0.0

1.6

—

3.1

—

(3013512) EKG study

135

1.36

0.41

3.9

4.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1.40

0.35

2.3

2.5

0.3

0.2

g/l

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.31

0.31

1.9

1.6

—

(40768797) Stomach Pathology biopsy report

1.23

0.26

1.3

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.34

0.26

1.7

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

509

1.35

0.24

23.2

17.1

139.5

139.7

mmol/l

0.19

497

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.21

0.0

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.21

0.0

1.5

—

(40768804) Tissue Pathology biopsy report

205

0.83

0.21

1.8

2.3

—

(3002032) Base excess in Venous blood by calculation

1.31

0.21

4.7

2.9

2.3

3.1

mmol/l

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.28

0.21

2.5

8.1

1.1

1.3

mmol/l

—

(3012544) pH of Venous blood

1.28

0.21

3.5

3.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

0.00

0.21

0.0

1.5

—

258.6

—

(40768793) Breast Pathology biopsy report

0.00

0.20

0.0

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.20

0.20

5.0

3.8

—

(3022145) Colonoscopy Study observation

1.17

0.20

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.26

0.19

1.7

—

(3002256) Pathology report gross observation

0.74

0.18

1.2

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

513

1.28

0.16

24.1

17.0

4.0

mmol/l

0.14

501

(40761511) CBC panel - Blood by Automated count

513

1.28

0.16

23.2

13.7

—

(3003694) ABO and Rh group [Type] in Blood

132

1.18

0.15

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

104

1.19

0.13

2.0

1.7

0.9

1.1

mg/l

—

(1761868) Lipid panel - Serum or Plasma

166

0.87

0.11

3.9

3.1

—

(3000492) Spirometry study

1.18

0.10

1.8

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.09

0.08

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

449

1.01

0.00

27.4

15.1

37.2

39.7

0.74

314

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

205

1.04

0.00

2.4

2.0

96.0

97.2

pmol/l

0.03

101

(3012441) Differential panel - Pleural fluid

0.00

0.0

2.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

3.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

0.0

1.4

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.0

1.6

—

(3045788) Cell count panel - Pleural fluid

0.00

0.0

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

0.0

1.6

—

(44790048)

0.00

0.0

2.3

—

(40768806) Pleura Pathology biopsy report

0.00

0.0

2.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.3

—

(44790047)

0.00

0.0

2.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

0.0

1.6

—

160.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.0

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.0

1.2

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

0.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.0

2.1

—

62.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.0

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

2.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.0

1.3

—

(44806118)

0.00

0.0

2.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

0.00

0.0

7.8

—

13.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

0.00

0.0

4.2

—

0.9

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.0

2.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.0

5.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.0

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(4146454)

0.00

0.0

3.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.5

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.0

1.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.0

1.0

—

(44790049)

0.00

0.0

2.3

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

2.3

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3035880) pH of Pleural fluid

0.00

0.0

1.2

—

(3000494) Fungus identified in Specimen by Culture

0.98

0.00

1.2

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

0.00

0.0

1.4

—

10.6

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.0

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.2

—

(3011648) Oxygen content in Venous blood

0.00

0.0

2.6

—

12.1

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

-0.00

0.0

2.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

-0.00

0.0

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

-0.00

0.0

2.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

-0.00

0.0

1.8

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

3.4

—

18.7

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

-0.00

0.0

1.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_IRIDOLENS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H7_IRIDOLENS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: H7_IRIDOLENS – Lens-induced iridocyclitis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

NAME	H7_IRIDOLENS
CONTROL_EXCLUDE	H7_SCLERACORNEA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H202
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H202
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Lens-induced iridocyclitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints